GLP-1/GLP-2 receptor (dual) drugs for Obesity
2 tracked GLP-1/GLP-2 receptor (dual) drugs in the Obesity race. The class explanation lives on the GLP-1/GLP-2 receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.
2 Phase 2
Head-to-head evidence: dapiglutide vs PG-102